Case Reports
doi: 10.1176/appi.psy.47.1.70.
Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease
Affiliations
- PMID: 16384811
- DOI: 10.1176/appi.psy.47.1.70
Item in Clipboard
Case Reports
Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease
Psychosomatics.
2006 Jan-Feb.
Abstract
The effect of quetiapine (an atypical antipsychotic with minimal extrapyramidal side effects) on motor as well as behavioral symptoms was studied in five consecutive patients with Huntington's disease in a long-term facility. Improvement of behavioral symptoms (i.e., psychotic symptoms, agitation, irritability, and insomnia) without worsening of motor functioning were noted.
Similar articles
-
Quetiapine in the management of psychosis secondary to huntington's disease: a case report.Can J Psychiatry. 2004 Jun;49(6):413. doi: 10.1177/070674370404900617. Can J Psychiatry. 2004. PMID: 15283541 No abstract available.
-
Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):448-53. doi: 10.1177/1533317506294775. Am J Alzheimers Dis Other Demen. 2006. PMID: 17267378 Clinical Trial.
-
Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.Ann Clin Psychiatry. 2008 Jan-Mar;20(1):15-20. doi: 10.1080/10401230701866870. Ann Clin Psychiatry. 2008. PMID: 18297582
-
Review of quetiapine side effects.J Clin Psychiatry. 2000;61 Suppl 8:31-3; discussion 34-5. J Clin Psychiatry. 2000. PMID: 10811241 Review.
-
[Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].Seishin Shinkeigaku Zasshi. 2007;109(7):657-63. Seishin Shinkeigaku Zasshi. 2007. PMID: 17969953 Review. Japanese. No abstract available.
Cited by
-
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues.Front Pharmacol. 2022 Oct 3;13:1007315. doi: 10.3389/fphar.2022.1007315. eCollection 2022. Front Pharmacol. 2022. PMID: 36263141 Free PMC article. Review.
-
Treatment of Irritability in Huntington's Disease.Curr Treat Options Neurol. 2010 Sep;12(5):424-33. doi: 10.1007/s11940-010-0088-3. Epub 2010 Jul 10. Curr Treat Options Neurol. 2010. PMID: 20730109 Free PMC article.
-
Symptomatic treatment of Huntington disease.Neurotherapeutics. 2008 Apr;5(2):181-97. doi: 10.1016/j.nurt.2008.01.008. Neurotherapeutics. 2008. PMID: 18394562 Free PMC article. Review.
-
Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration.BMC Med Genomics. 2017 Dec 28;10(Suppl 5):79. doi: 10.1186/s12920-017-0311-0. BMC Med Genomics. 2017. PMID: 29297383 Free PMC article.
-
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w. Epub 2024 May 19. Arch Pharm Res. 2024. PMID: 38764004 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
